Cromos Pharma celebrates Breast Cancer Awareness Month Breast cancer is the most commonly occurring cancer in women and the second only to lung cancer as the most common cancer overall. The developed nations in North America and Western Europe lead the world in incidence (well over 60 and up to 95 per 100,000 women ages 0-69). And yet, while mortality rates in
Cromos™ Pharma shares its experience with clinical trials in Kazakhstan in Applied Clinical Trials Cromos™ Pharma has published an article on Clinical trials in Kazakhstan in Applied Clinical Trials journal. The company has recently initiated 3 late stage trials and the article describes its experience with the emphasis on the regulatory approval process. Please follow this link to access the article.
Cromos Pharma begins operations in Kazakhstan Cromos™ Pharma, a premier full service regional contract research organization (CRO) announced that it has begun operations in Kazakhstan. The company has initiated three phase III trials in the region with the fourth study nearing finalization of the prelaunch phase. “Kazakhstan is an uncharted territory for most clinical trial organizations and as such it epitomizes
